Recurrence Patterns and prognostic Factors in Patients with limited-disease SCLC after definitive Chemoradiotherapy

被引：0
|
作者：
Heinzelmann, F. [1 ]
Wagner, B. [1 ]
Welz, S. [1 ]
Gani, C. [1 ]
Zips, D. [1 ]
机构：
[1] Eberhard Karls Univ Tubingen, Univ Klin Radioonkol, Tubingen, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2018年 / 194卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V14-6
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [1] The Glasgow Prognostic Score as a Predictor of Survival after Chemoradiotherapy for Limited-Disease Small Cell Lung Cancer
    Endo, Satoshi
    Imai, Hisao
    Shiono, Ayako
    Hashimoto, Kosuke
    Miura, Yu
    Okazaki, Shohei
    Abe, Takanori
    Mouri, Atsuto
    Kaira, Kyoichi
    Masubuchi, Ken
    Masubuchi, Takeshi
    Kobayashi, Kunihiko
    Minato, Koichi
    Kato, Shingo
    Kagamu, Hiroshi
    ONCOLOGY, 2024,
  • [2] Recurrence Pattern, Treatment Modalities, and Prognostic Factors After Definitive Chemoradiotherapy for Recurrent Esophageal Cancer
    Akahane, Keiko
    Hatanaka, Shogo
    Kawahara, Masahiro
    Endo, Masashi
    Fukuda, Yukiko
    Okada, Kohei
    Ogawa, Kazunari
    Takahashi, Satoru
    Nakamura, Michiko
    Saito, Masaaki
    Oyama-Manabe, Noriko
    Shirai, Katsuyuki
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (02) : 809 - 819
  • [3] Accelerated Hypofractionated Radiotherapy and Concurrent Etoposide / Cisplatin in Patients with Limited-Disease SCLC (LD-SCLC)
    Abdelwahab, Sherif
    Elghamry, Wesam
    Azmy, Ali
    Fouad, Iman
    Elsayed, Zeinab
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S626 - S626
  • [4] Definitive chemoradiotherapy of limited-disease small cell lung cancer: Retrospective analysis of new predictive factors affecting treatment results
    Komatsu, Tetsuya
    Oizumi, Yukio
    Kunieda, Etsuo
    Tamai, Yoshifumi
    Akiba, Takeshi
    Kogawa, Asuka
    ONCOLOGY LETTERS, 2011, 2 (05) : 855 - 860
  • [5] Prognostic Factors for Patients with Esophagus Carcinoma after primary definitive Radiotherapy or Chemoradiotherapy
    Haefner, M. F.
    Krug, D.
    Lang, K.
    Koerber, S. A.
    Uhlmann, L.
    Debus, J.
    Sterzing, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 : 106 - 106
  • [6] Salvage Surgery for Patients With Local Recurrence or Persistent Disease After Treatment With Chemoradiotherapy for SCLC
    Joosten, Pieter J. M.
    Winkelman, Toon A.
    Heineman, David J.
    Hashemi, Sayed M. S.
    Bahce, Idris
    Senan, Suresh
    Paul, Marinus A.
    Hartemink, Koen J.
    Dahele, Max
    Dickhoff, Chris
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (05):
  • [7] Definitive Chemoradiotherapy of Limited-disease Small Cell Lung Cancer: Retrospective Analysis of New Predictive Factors Affecting the Treatment Results
    Komatsu, T.
    Oizumi, Y.
    Kunieda, E.
    Tamai, Y.
    Akiba, T.
    Kogawa, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S532 - S533
  • [8] Clinical outcome of chemoradiotherapy in patients (pts) with limited-disease small-cell lung cancer (LD-SCLC) with ipsilateral pleural effusion
    Niho, S.
    Kubota, K.
    Yoh, K.
    Goto, K.
    Ohmatsu, H.
    Saijo, N.
    Nishiwaki, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] EARLY CONCURRENT CHEMORADIOTHERAPY FOR LIMITED-DISEASE SMALL CELL LUNG CANCER IN ELDERLY PATIENTS
    Okamoto, Kunio
    Okamoto, Isamu
    Takezawa, Ken
    Tanaka, Kaoru
    Tanizaki, Junko
    Makimura, Chihiro
    Hayashi, Hidetoshi
    Tachibana, Izumi
    Nishimura, Yasumasa
    Fukuoka, Masahiro
    Nakagawa, Kazuhiko
    ANNALS OF ONCOLOGY, 2010, 21 : 27 - 27
  • [10] Chemoradiotherapy in limited-disease small-cell lung cancer
    Fukuda, Minoru
    Ogawara, Daiki
    Nakamura, Yoichi
    Kohno, Shigeru
    LUNG CANCER MANAGEMENT, 2012, 1 (02) : 135 - 143
12345